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The goals of Working Together to Manage Diabetes: A Guide for Pharmacists, 
Podiatrists, Optometrists, and Dental Professionals is to reinforce consistent 
diabetes messages across the four disciplines, pharmacy, podiatry, optometry, 
and dentistry (PPOD), and to promote a team approach to comprehensive 
diabetes care that encourages collaboration among all care providers.
The following are the learning objectives for these materials:
After this activity, the participant will be able to…
 • Identify the ABCs of diabetes and their role in preventing complications.
 •  Name key messages that PPOD providers should all convey to patients with 
diabetes.
 •  Describe the key concerns for drug management and foot, eye, and oral 
health care for people with diabetes.
 • Identify the results of the Diabetes Prevention Program (DPP).
The target audiences that may best benefit from these materials include 
pharmacists, podiatrists, optometrists, dentists, dental hygienists, physicians, 
nurses, dietitians, and others who provide care to people with or at risk for 
diabetes.
Working Together to Manage Diabetes is a cross-training document. It is not 
a comprehensive guide to all diabetes concerns in any one of the PPOD 
disciplines, but is instead a “key issues” guide to messages that every health 
care professional can give to support comprehensive care.
ix
Hypothetical Case Examples
 •  A 70-year-old woman with diabetes tells her eye care provider that her 
blurred vision is such a problem that she is afraid to cut her toenails. 
She states “They are so long, my shoes don’t fit!” She has worn oversized 
bedroom slippers to the appointment. The eye care provider asks the 
patient to take off her slippers, and finds overgrown, thickened toenails 
that have curled around and are cutting the skin. The woman has little 
sensation and has noticed no pain though several areas are red. The eye 
care provider arranges for the patient to be seen that day by her primary 
care provider or a podiatrist for foot care and emphasizes the importance 
of prompt treatment to avoid serious injury.
 •  A dental hygienist notes that her patient smokes. She tells him that smoking 
can cause oral cancer and she describes the impact tobacco use can have 
on increasing diabetes complications. She asks the patient to consider 
quitting as an important step in controlling his diabetes and gives him the 
1-800-QUITNOW number.
 •  A 40-year-old woman asks her local pharmacist for advice on reading 
glasses. She says, “I must be getting older, everything is just blurry.” The 
pharmacist uncovers a history of diabetes, diagnosed the previous year, 
but discovers that the patient never returned for follow-up. The pharmacist 
advises the woman that her blurred vision may not be a need for reading 
glasses but in fact a sign of diabetes and arranges for the woman to be 
seen by a primary care provider and eye care provider for follow-up.
 •  A podiatrist notices his 35-year-old patient with diabetes has terrible breath 
and asks about it. The patient is embarrassed but admits that he has 
noticed a bad taste as well. A quick look in the patient’s mouth reveals 
inflamed, swollen gums with pus at the gum line. The podiatrist describes 
the link between periodontal disease and poor blood glucose control and 
stresses the need for urgent dental attention for a possible abscess. 
The podiatrist’s office helps the patient obtain a same-day dental 
appointment for care.
 •  A dentist needs to schedule a patient for several procedures and asks about 
the timing of the patient’s morning insulin. The patient is confused about his 
complicated medication regimen and asks, “Should I just skip all medicines 
that day until after you work on my teeth?” The dentist phones the patient’s 
pharmacist to arrange a consultation. The pharmacist collaborates with the 
primary care clinician to develop an individualized medication schedule 
and advises the patient and his dentist on whether to hold medications the 
day of the procedure.
 •  A man with diabetes of more than 20 years duration, and neuropathy, 
asks the pharmacist for an Ace wrap and advice on care of his foot, which 
is warm, red, and swollen. The man recalls no trauma and there is no 
evidence of skin breakdown or an open wound. The pharmacist arranges 
for a same-day referral to a podiatrist for possible cellulitis. Upon physical 
exam and X ray of the affected foot, the podiatrist diagnoses Charcot 
arthropathy and implements a plan of treatment with no weight bearing and 
close follow-up, with casting, until the edema resolves.
x
Where can I ever find the time?
How realistic is it for a busy optometrist to look at a patient’s feet? 
Or any of the scenarios described above? You have limited time 
to provide patient care. But research has shown that health messages 
direct from the provider, e.g., “I recommend that you…” are more 
effective than generalizations or third-person recommendations 
such as “You should see someone about that…” or “The American 
Diabetes Association says that…”
You don’t need to be an expert or do a thorough exam to identify that 
a problem needs attention by a specialist. It takes less than a minute 
to look at a person’s foot, mouth, or eye, or to ask a few questions 
about medications, supplies, or tobacco use. You reinforce the 
importance of preventive care if you take time to check a complaint 
yourself before recommending referral to another provider. Support 
comprehensive diabetes care: think beyond your own discipline to 
identify other potential problems. Then refer with an “I recommend…” 
message. Patients will appreciate your concern for their health and 
well-being as a whole. Establishing a referral system with other 
providers can improve your patient’s health and increase your referral 
base as well.
Diabetes: A Major Health Problem
Section 1
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Diabetes is a serious, common, costly, but controllable disease. Diabetes 
is the sixth leading cause of death in the United States and affects almost 21 
million Americans, an estimated 6.2 million of whom are as yet undiagnosed 
(1). In 2002, diabetes cost the nation an estimated $132 billion in direct and 
indirect costs (2). Diabetes is the number one cause of lower limb amputation 
not related to trauma, the number one cause of acquired blindness, and the 
number one cause of kidney disease leading to dialysis in the United States. 
Diabetes is a major contributor to cardiovascular disease, the number one 
cause of death in this country. About 65% of people with diabetes die from 
cardiovascular disease (3).
Diabetes prevalence is rapidly increasing. Figure 1 shows self-reported rates 
of diabetes gathered through the Behavioral Risk Factor Surveillance Study 
(BRFSS) by state. Diabetes prevalence has tripled from 1990 to 2005, and 
in some states more than 25% of the adult population aged 20 years and 
older has diabetes. The number of people with diabetes in the United States 
is projected to reach 39 million by the year 2050 (4). If current trends 
continue, 1 in 3 Americans will develop diabetes sometime in his or her 
lifetime, and those with diabetes will lose, on average, 10 to 15 years of life (5).
Types of Diabetes
Type 1 diabetes. Type 1 diabetes (formerly known as insulin-dependent or 
juvenile-onset diabetes) is an autoimmune disease that is distinguished by the 
destruction of insulin-producing beta cells. Type 1 diabetes can occur at any 
age, but onset usually begins in childhood or the young adult years. People 
with type 1 diabetes are ketosis-prone, although ketoacidosis can develop 
in type 2 diabetes as well. People with type 1 diabetes must take insulin 
daily. Delivery mechanisms for insulin include injection, insulin pump, and 
inhalation, although at this time inhalation must be combined with another 
delivery method. For optimal management, people with type 1 diabetes must 
test their blood glucose levels several times a day, follow an individualized 
meal plan, and engage in regular physical activity.
Type 2 diabetes. Formerly known as non-insulin-dependent or adult-onset 
diabetes, type 2 diabetes is related to insulin resistance. The pancreas 
continues to make insulin, but the insulin is not used well by other body 
tissues. Eventually, insulin production decreases. People with type 2 diabetes 
Diabetes Impact*
 • Affects almost 21 million people in the United States.
 • One third (more than 6 million people) are as yet undiagnosed.
 • Costs more than $132 billion/year in health care expenditures.
 • One of the six leading causes of death in the United States.
 • Number 1 cause of acquired blindness.
 • Number 1 cause of kidney failure.
 • Number 1 cause of non-traumatic amputation.
 • Major contributor to cardiovascular disease, the #1 cause of death.
* Source: 2005 Diabetes Fact Sheet
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may be treated with insulin, oral medications, or a combination of both 
or be controlled with a food plan and physical activity alone. Type 2 diabetes 
affects 9.6% of the U.S. population aged 20 years and older, and 20.9% 
of the population aged 60 years or more, occurring more often in adults 
who are overweight and sedentary (3). In recent years, however, it has been 
seen increasingly in young people, including children. The prevalence of type 
2 diabetes in younger age groups is of special concern because the risk of 
complications increases with the disease’s duration.
Type 2 diabetes disproportionately affects African Americans, Hispanics/
Latinos, American Indians, and Alaska Natives, and some groups of Asians 
and Native Hawaiians or other Pacific Islanders. African Americans and 
Hispanic/Latino Americans are about twice as likely to have diabetes as non-
Hispanic/Latino whites in a similar age group. Some populations of American 
Indians have the highest rates of diabetes in the world.
Gestational diabetes is a form of glucose intolerance diagnosed in some 
women during pregnancy. Gestational diabetes occurs more frequently among 
African Americans, Hispanic/Latino Americans, and American Indians. It is 
also more common among obese women and those with a family history 
of diabetes. During pregnancy, gestational diabetes requires treatment to 
normalize maternal blood glucose levels to avoid complications in the infant. 
After pregnancy, 5% to 10% of women with gestational diabetes are found to 
have type 2 diabetes. Women who have had gestational diabetes have a 20% 
to 50% chance of developing diabetes in the next 5 to 10 years (5).
Other types of diabetes result from specific genetic conditions (such as 
maturity-onset diabetes of youth), surgery, drugs, malnutrition, infections, and 
other illnesses. Such types of diabetes account for 1% to 5% of all diagnosed 
cases.
Diabetes and Obesity Trends
The development of type 2 diabetes is multifactorial, with insulin resistance, 
sedentary lifestyle, increasing age and increasing obesity contributing to this 
increase. A body mass index (BMI) of 25 or more (> 23 for Asian Americans 
and > 26 for Pacific Islanders) is a risk factor for the development of type 2 
diabetes. Figure 2 shows the parallel increases in the prevalence of diabetes 
and mean body weight by year in the United States from 1990 to 2000 (6–8). 
As of 2005, approximately two-thirds of American adults were overweight or 
obese, with BMI more than 25.
 • The prevalence of obesity has increased by 61% since 1991.
 • More than 60% of U.S. adults are overweight.
 • BMI and weight gain are major risk factors for diabetes.
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Figure 2. Diabetes and Obesity
Source: Behavioral Risk Factor Surveillance System, CDC.
15%–19%No data
available
































































































Diabetes Morbidity and Mortality
Adults with type 2 diabetes are two to four times more likely to have heart 
disease or suffer a stroke than those without diabetes. Cardiovascular disease 
is the major cause of death for people with diabetes. They are also at risk for 
other complications, such as blindness, kidney disease, amputations, nervous 
system disease, and oral complications, including gum or periodontal disease 
and tooth loss (3).
Fortunately, many studies in recent years have demonstrated effective 
interventions to help prevent or delay diabetes complications as well as the 
disease itself (9–21).





Impact of glycemic control
Table 1 summarizes some of the major studies that have demonstrated the 
impact of glycemic control on complications prevention. The Diabetes Control 
and Complications Trial (DCCT) showed that tight glycemic control reduced 
risk of microvascular disease in persons with type 1 diabetes (76% reduction 
in eye disease overall with 63% reduction in retinopathy, 54% reduction in 
nephropathy, 60% reduction in neuropathy) (9, 10). The United Kingdom 
Prospective Diabetes Study (UKPDS) showed that among people with type 2 
diabetes, improved glycemic control (average A1c = 7% vs. average A1c = 
7.9% in the conventionally treated group) led to a reduction in risk of 25% for 
microvascular disease overall, 17%–21% for retinopathy, and 24%–33% for 
albuminuria. Lower A1c values also reduced the incidence of macrovascular 
disease with a 16% reduction in myocardial infarction, and contributed to a 
24% decrease in cataract extraction (12).
Table 1. Impact of Glycemic Control (9–11, 26)
Impact of Blood Pressure Control
The United Kingdom Prospective Diabetes Study (UKPDS) found that 
improved glycemic control not only reduced diabetes complications, but 
also demonstrated the impact of improved blood pressure control. UKPDS 
participants in the “tight” control blood pressure group maintained on average 
for the duration of the study 10 mm Hg lower systolic and 5 mm Hg lower 
diastolic pressures than controls. Table 2 summarizes the impact of that 
reduction. Improved blood pressure control (average of 144/82 mm Hg vs. 
154/87 mm Hg control) during the 8 years led to a reduction in risk of 34% 
for retinopathy, 47% for vision loss, 37% overall for microvascular disease, 
56% for heart failure, and 44% for stroke incidence (12).
Good Glycemic Control (Lower A1C) 








t Not statistically significant
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Table 2. UKPDS: Impact of Blood Pressure Control 
in Diabetes (12)
Furthermore, clinical trials, such as ABCD (Appropriate Blood Pressure Control 
in Diabetes Trial) and HOPE (Heart Outcomes Prevention Evaluation Study), 
also show that use of an ACE inhibitor reduces the risk of heart attack, stroke, 
or cardiovascular death by 25%–30% in patients with type 2 diabetes, and 
slows the progression of the kidney damage of diabetes (14).
Impact of Cholesterol and Other Lipid Control
Among people with diabetes, 67% have one or more lipid abnormalities. 
Multiple studies, including CARE (Cholesterol and Recurrent Events Trial) and 
4S (Scandinavian Simvastatin Survival Study), have shown that lipid therapy 
can reduce the risk of coronary events such as nonfatal heart attacks and 
CVD-related deaths, as summarized in Table 3 (13, 19).
Table 3. CARE and 4S: Impact of Cholesterol Control 
in Diabetes
Tight blood pressure control 
reduces risk of:
 • Retinopathy progression (34%)
 • Vision loss (47%)
 • Diabetes-related deaths (32%)
 • Microvascular disease (37%)
 • Heart failure (56%)
 • Stroke (44%)
UK Prospective Diabetes Study Group (UKPDS) 33: Lancet. 1998; 352: 837-853.
Lipid therapy reduces risk of coronary 
events
Cholesterol and Recurrent Events Trail (CARE)
Reduced risk by 24%
 
Scandinavian Simvastatin Survival Study (4S)
Reduced risk by 42% to 55%
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Preventing Complications
Comprehensive diabetes care is a team effort involving self-management 
behaviors (see “Self-Management Support” at the end of this section) by the 
patient and preventive care services by health care providers. At routine visits, 
providers of foot, dental, and eye care and drug therapy management can 
monitor, prevent, and treat complications, not only for conditions specific to 
their professional discipline, but for the patient’s overall health. Cardiovascular 
disease (CVD), including heart disease and stroke, is the number one cause of 
death for people with diabetes. All health care providers can contribute to the 
reduction of risk factors for CVD, and potentially reduce other complications 
as well, by reinforcing control of the ABCs of diabetes:
A    is for A1C, previously known as hemoglobin A1C—a test that reflects 
average blood glucose over the last 3 months. The goal for most people 
with diabetes is <7. An A1C of 7 corresponds to an average blood 
glucose level of 150 mg/dL.
B    is for blood pressure. The goal for most people with diabetes 
is <130/80 mm Hg.
C    is for cholesterol. The goal for people with diabetes is an LDL level 
of <100 mg/dL, an HDL level of >40 mg/dl in men and >50 
in women, and triglycerides level of <150
Source: American Diabetes Association Standards of Medical Care, Diabetes Care 29 
(Suppl.1): S4-S42, 2006 (27).
Treatment Goals for the ABCs of Diabetes
A1C < 7 %
Preprandial plasma glucose 90–130 mg/dl
Peak postprandial plasma glucose < 180 mg/dl
(usually 1 to 2 hours after the start of a meal)
Blood pressure (mmHg)
Systolic Diastolic
< 130 / < 80
Cholesterol – Lipid Profile (mg/dl)
LDL Cholesterol < 100




•  A1C goal as close to normal (< 6%) as possible without significant 
hypoglycemia.
•  Less stringent AIC goal for people with severe or frequent 
hypoglycemia.
• Lower blood pressure goals for people with nephropathy.
The NDEP promotes control of the ABCs of diabetes and use of the 
term A1C for Hemoglobin A1c.
Source: Numbers At A Glance www.ndep.nih.gov 




Diabetes Management And Team Care
People with diabetes can take action to lower their risk for heart attack, 
stroke, and other diabetes complications by controlling the ABCs, following 
an individualized meal plan, engaging in regular physical activity, avoiding 
tobacco use, and taking medicines as prescribed. A multidisciplinary team 
approach is critical to success in diabetes care and complications prevention. 
Medical nutrition therapy education by a dietitian is critical to developing an 
individualized meal plan. A certified diabetes educator not only teaches factual 
information about diabetes but also provides self-management support, 
enabling the patient to gain skills in problem solving and self-care. All health 
care providers can help by discussing how self-management and diabetes 
control relate to preventing complications.
Tools for health care providers and patients can be found on the NDEP Web 
site at http://ndep.nih.gov/. The NDEP Team Care monograph, available at 
http://ndep.nih.gov/diabetes/pubs/TeamCare.pdf (28), can tell you more 
about the advantages of team care and how to form a team, and gives 
examples of effective team care. For information on the link between diabetes 
and cardiovascular disease, see http://ndep.nih.gov/control/cvd.htm.
Self-management Support
Patient self-management support is important in helping people achieve goals 
in both diabetes control and prevention. In contrast to traditional patient 
education, in which information is delivered to the person with diabetes, 
self-management support involves teaching the behavioral skills needed to 
make decisions about diabetes management in daily life. Self-management 
support is a partnership between patient and health care provider. It involves 
collaborative goal-setting, problem-solving, and individualized behavior-
change plans that address concerns identified by the patient as highest priority. 
All health care providers can provide self-management support, reinforcing 
patient problem-solving skills and giving consistent, proactive health care 
messages.
Self-management support relies on principles of self-efficacy (confidence in 
one’s ability to perform a task successfully), short-term action plans, realistic 
goal setting, and proactive identification of barriers to optimal diabetes 
control. Self-management support involves asking the person with diabetes 
to identify an accomplishable action he or she would like to take in changing 
a behavior (e.g., walking 10 minutes a day before dinner starting tomorrow), 
not telling the individual what to do. Self-management support also includes 
trouble-shooting about missed appointments, establishing routines around 
daily activities such as dental hygiene, foot care or blood glucose testing, and 
helping people overcome the barriers to receiving regular screening exams for 
eye, foot and oral health.
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Self-management support does not replace traditional patient education but 
complements it. Because diet and physical activity patterns are important 
in both diabetes control and prevention, it is important that all providers 
participate in patient self-management support for healthy food choices and 
regular exercise. Prompting a patient to consider and plan for challenging 
events is self-management support. Problem solving discussions can help 
prepare the patient to deal effectively with self-management issues.
Self-Management Support
At each visit, the provider and patient need to consider the following 
patient self-management tasks. How to:
 • Take care of diabetes and it’s complications.
 • Incorporate behavior changes into daily life activities.
 • Manage emotions, including future concerns.
Source: http://www.betterdiabetescare.nih.gov/WHATpatientcentereddimensions.htm.
Self-management Support Example 
A 50-year-old man with diabetes and obesity has been told he would 
benefit from a less calorie-dense diet, but he confesses to you that he 
just doesn’t think he can do it. You are not a dietitian—how can you 
help him make such a change?
 •  Ask what he thinks will be the biggest challenge to making these 
changes.
 • Ask if he can identify one thing he can do differently.
 • Reinforce all positive steps, even if small.
 •  Refer him to a dietitian or diabetes educator who can continue 
support.
 • Follow up at the next visit by asking about progress.
In this example, the man might identify eating dessert as a challenge, 
and a change in portion size (e.g., eating one scoop of ice cream 
instead of two) as one thing he can do differently. This is an 
acceptable short-term goal. It is a step in the right direction. All health 
care providers can contribute to self-management support by helping 
patients plan and troubleshoot the many daily decisions they must 
make for diabetes control.
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Self-management support also involves follow up: asking about progress 
in achieving behavioral goals and sustaining problem-solving skills (29).
To learn more about self-management support, consult the NDEP’s Better 
Diabetes Care Web site www.betterdiabetescare.nih.gov.
Psychosocial considerations and comorbid conditions such as depression can 
adversely influence self-management behaviors. Multi-disciplinary team care 
includes working closely with social services, certified diabetes educators, 
and mental health specialists who can help address these concerns. More 
information can be found in the NDEP Team Care monograph available 
at http://ndep.nih.gov as well as at www.betterdiabetescare.nih.gov.




What to Discuss with Patients with Diabetes
This section provides messages that you as a health care provider should 
discuss with people with diabetes about foot, eye, and oral health and 
about drug therapy management. The bullets highlight questions to ask 
and information to discuss about diabetes-associated risks, the benefits of 
comprehensive care, the need for regular medical examinations, symptoms to 
look for, and self-care issues. You can discuss these topics, when appropriate, 
over a series of patient visits; you need not cover all the material with every 
patient. Guidelines for referral to other health care providers are also 
provided.
Promote the ABCs—A1C, Blood Pressure, and 
Cholesterol
It is important to control risk factors for cardiovascular disease. Ask about the 
ABCs of diabetes.
 •  Ask: “Do you know your ABC goals and how to reach them?” Recommend 
working with the health care team to determine both long-and short-term 
goals for each ABC. 
 •  Advise: “You can take action to prevent or delay type 2 diabetes 
complications.” Controlling the ABCs can reduce the risk for heart attack 
and stroke, and inform them that poor control can lead to problems in foot, 
eye, and oral health. Explain that screening and team care can prevent 
complications.
 •  Assist: Refer to a primary care provider. Give your patients resources 
to help them make healthy changes by contacting the National Diabetes 
Education Program (NDEP) for FREE information and materials on diabetes 
prevention and control. Recommend that they call 1-800-438-5383 or visit 
www.ndep.nih.gov.
Key Messages all Health Care Providers 
Can Reinforce
• Emphasize the importance of metabolic control (ABCs).
• Promote a healthy lifestyle.
• Explain the benefits of diabetes comprehensive team care.
•  Recommend routine exams for complication prevention: oral health, 
comprehensive foot exam, complete dilated eye exam.
• Reinforce self-exams.
• Recognize danger signs and seek help.
• Promote pharmacist role in drug therapy management.
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Promote a Healthy Lifestyle
Healthy lifestyle is key to diabetes control.
 •  Weight. Advise people with diabetes to aim for a healthy weight. Emphasize 
the importance of setting stepwise and realistic goals for weight reduction.
 •  Healthy Food Choices. Encourage meal planning that includes a variety 
of foods and controls portion sizes and snacks. Increasing fiber and limiting 
saturated fats and salts will help control blood glucose, blood pressure, and 
cholesterol. Recommend consultation with a dietitian for additional help 
with meal planning and learning how to make healthy food choices.
 •  Physical activity. Advise people with diabetes that moderate physical 
activity (such as walking) can help control the ABCs and prevent complications.
 •  Self-management. Ask people with diabetes to identify their high priority 
concerns. Prompt them to plan for challenging situations and set short-term 
achievable goals. Compliment them on any steps taken toward these goals. 
See “Self-Management Support” in the previous section.
 •  Tobacco. Ask about tobacco use. Encourage people with diabetes to 
avoid smoking and using smokeless tobacco products. Recommend calling 
the FREE tobacco quit line 1-800-QUITNOW. People who use tobacco are 
at greater risk for stroke; heart, kidney, and eye diseases; nerve damage; 
and lower-extremity complications. To learn more about tobacco cessation 
strategies, consult the CDC’s Tobacco Information and Prevention Source 
(TIPS) Web site at www.cdc.gov/tobacco/.
Explain the Risks of Disease and Benefits of Care
People with diabetes make daily decisions that affect their diabetes control. 
Cornerstones of diabetes self management include meal planning, physical 
activity, and self monitoring of blood glucose. Routine self-care behaviors 
also impact diabetes complications prevention. See appendix C for a list of 
common diabetes-related foot, eye, and oral health complaints and examples 
of inappropriate self-care.
At each patient encounter, remind patients of the risks of diabetes 
complications and the benefits of foot, eye, and oral health care as well as 
drug therapy management. Ask about annual screening exams. Ask about 
routine self-care behaviors. Assess symptoms that warrant urgent referral.
 •  Foot health. Ask people with diabetes if they know how diabetes affects 
their feet. Explain that diabetes raises the risk of foot ulcers, which can lead 
to amputation, and that proper foot care reduces their risk.
 -  Foot exams. Ask people with diabetes if they have had a 
comprehensive foot examination (including a sensory exam with a 
monofilament) in the past year. Recommend a comprehensive annual 
foot exam by a podiatric physician or primary care clinician and a foot 
inspection (visual foot check) at every primary care provider visit.
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 -  Daily foot care. Ask about proper daily foot care. People with 
neuropathy may not notice injuries as they do not feel pain. Advise all 
people with diabetes to take the following steps:
 -  Examine feet daily, both by looking and touching. Look for cuts, 
bruises, puncture wounds, corns or calluses, areas of redness, or 
pus. Seek podiatric medical advice right away for these symptoms.
 -  Clean feet (both skin and nails) daily and dry the spaces between 
the toes gently. Check the insides of shoes for objects before putting 
them on.
 -  Never walk barefoot, not even indoors. Wear appropriate footwear, 
such as athletic or walking shoes that fit well and cover the feet (i.e., 
NOT sandals).
 -  Foot symptoms. Ask about foot symptoms and recommend prompt 
podiatric medical attention for bruises, lacerations, puncture wounds, 
swelling, and areas of redness or pus from any area of the foot. 
These signs and symptoms can be the earliest harbingers of serious 
injury leading to amputation. Be proactive.
 -  Refer people with these symptoms to a podiatric physician or to their 
primary care provider.
 •  Eye health. Advise people with diabetes about the risk of diabetic 
retinopathy, a leading cause of blindness in adults and one that may 
be prevented or delayed by good control of blood glucose. People with 
diabetes also may be at greater risk for eye problems such as cataracts and 
glaucoma. Ocular symptoms associated with diabetes include fluctuation in 
visual acuity, double vision, dry eye, recurrent lid infections (blepharitis) and 
changes in color vision.
 -  Eye exams. Ask when the person with diabetes last had 
a comprehensive dilated eye exam by an optometrist or an 
ophthalmologist. Reinforce the need for regular screening eye exams 
to prevent or delay the onset of blindness due to diabetic retinopathy. 
Most people with diabetes should have a dilated eye examination by 
an optometrist or an ophthalmologist annually. An eye care provider 
may suggest less frequent exams (every 2–3 years) in the setting of a 
normal eye exam (30). Examinations will be needed more frequently if 
retinopathy exists or is progressing.
 -  Eye care. Advise people with diabetes to report eye symptoms to 
their health care provider and to maintain a current prescription for 
eyeglasses, contact lenses, or low-vision aids.
 -  Eye symptoms. Ask about eye symptoms and their frequency and 
duration. Encourage people with diabetes to report any changes in their 
eyes or vision, such as sudden onset of blurriness, seeing spots, 
or persistent redness or pain to their health care provider.
 -  If there is sudden change in vision, refer the person at once to an 
optometrist or ophthalmologist.
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 •  Oral health. Explain the link between poor control of blood glucose and 
periodontal (gum) disease. Good oral health may help control diabetes—
and controlling blood glucose levels my contribute to improved oral health.
 -  Oral health exams. Ask the date of the last dental/oral health exam. 
Stress the importance of good oral hygiene and regular exams, including 
regular cleanings performed by a dental hygienist or dentist to prevent 
periodontal disease. Even people with who wear dentures or have 
no teeth need an oral health exam once a year to screen for cancer, 
infection, or other lesions.
 -  Daily oral care. Advise about the need to brush the teeth after eating 
and to floss at least once a day. If dentures are worn, advise about their 
care: daily cleaning and a dental visit if dentures become loose 
or irritation develops.
 -  Monthly oral self exam. Advise people with diabetes to do a 
monthly self exam and to contact their dentist if they notice signs 
of infection, such as sore, swollen, or bleeding gums; loose teeth; 
or mouth ulcers.
 -  Oral symptoms. Ask about oral health symptoms that may indicate 
infection such as a bad taste or bad breath, or pain. Evaluate whether 
an acute problem, such as infection, is present that requires immediate 
attention.
 -  Refer individuals with oral findings or complaints to a dentist or 
periodontist and/or their primary care provider, as indicated.
 -  Oral infections may worsen glycemic control, progress to serious 
complications quickly, and need prompt treatment.
 •  Drug therapy management. Discuss the benefits of proper drug 
therapy management. Recommend that your patients with diabetes talk 
with their pharmacist about how to get the most benefit from medications 
by individualizing dosage regimens. Pharmacists can provide regular 
medication reviews to ensure that people with diabetes take medications 
as prescribed and understand the risks of using over-the-counter (OTC) 
medications.
 •  Regular Medication Review. Advise people with diabetes that regular 
medication reviews, individualized drug regimens, and screening for 
interactions and side effects from medications, OTC medications, herbal 
products, and supplements can help them get the most from their drug 
therapy.
 -  Medications. Ask people with diabetes if they take their medication 
exactly as prescribed. Advise them to talk to their pharmacist or primary 
care provider if they are unable to follow the medication plan prescribed.
 -  Remind people with diabetes that they should seek advice from 
their pharmacist or primary care provider before taking any OTC 
medications, herbal products, or other supplements.
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 -  Drug Therapy Management Medication-related symptoms.
 -  Ask at every visit about medication use.
 -  Ask people with diabetes to report any changes in symptoms, 
medical conditions, medications, doses, supplements, or lifestyle 
to all health care providers.
 -  Refer individuals to a pharmacist or primary care provider, 
as indicated, for evaluation.
 •  Selection and use of a blood glucose meter. Refer people with 
diabetes to a pharmacist or diabetes educator for help in choosing 
an appropriate blood glucose meter, learning how to use it, and under-
standing the results to check how medications are working.
 •  ABC monitoring. Ask your patients with diabetes when they last had their 
A1C, blood pressure, and cholesterol levels checked and if they know the 
results of these tests.
 •  Personal ABCs. Ask if they know what they need to do to control their 
ABCs. Advise about the ABC goals: A1C <7, BP <130/80, LDL cholesterol 
<100. Even if a person has not reached these goals, there is benefit in 
decreasing their A1C, blood pressure, and cholesterol towards these goals.
How can a busy health care provider find the 
time to give the key team care messages?
Suggestions:
 • Don’t give every message at one appointment.
 •  Customize and prioritize messages according to the 
patient’s needs.
 •  Establish a blueprint of messages over a period of client 
appointments.
 •  Provide patient with a computer generated reminder of key 
messages discussed at each appointment.
 •  Document what is accomplished at each appointment and the 
patient’s response.
 • Create pamphlets for office or use NDEP materials.
 • Include key messages in office newsletters.
 • Offer health awareness program for patients with diabetes.
 • Establish referral base in the community.
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This table outlines messages that health care providers should discuss with people who have diabetes 
regarding foot, eye, and oral health and about drug therapy management.
Health care providers in these four disciplines are well positioned to deliver these overarching prevention messages, 
communicate the need for metabolic control, and encourage multidisciplinary team diabetes control.
Promote the ABCs—A1C, Blood Pressure, and 
Cholesterol:
Ask about Health Examinations:
–  Controlling the ABCs can prevent complications and 
reduce the risk of stroke and heart attack.
– Foot exams.
–  Ask: “Do you know your ABC goals and how to reach 
them?”
– Eye exams.
–  Explain that poor ABC control can also lead to problems 
in foot, eye, and oral health.
– Oral health exams.
– Drug therapy management.
Promote a Healthy Lifestyle: – ABC monitoring and control.
– Weight control.
– Healthy food choices. Support Self-Care Behaviors:
– Daily physical activity. – Daily foot care.
– Support self management. – Eye care.
– No tobacco use (call 1-800-QUITNOW for help). – Daily oral care.
– Monthly oral self-exam.
Explain the Risks and Benefits of Diabetes 
Comprehensive Control:
– Selection and use of a blood glucose monitor.
– Foot health. – Know your ABC goals and how to reach them.
– Eye health. – Medication management.
– Oral health.





Table 4. Summary—What to Discuss with Patients with Diabetes
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The information below lists some of the common issues specific to foot, eye, and oral health, and drug therapy 
management.
When health care professionals understand the diabetes care issues of other disciplines, they can recognize symptomatic 
concerns warranting urgent referral, reinforce annual screening recommendations, and contribute to a proactive approach 
to diabetes care beyond the scope of their particular discipline.








Diabetes drug management 
issues:
– Neuropathy – Retinopathy – Changes in the oral cavity – Improper drug choice
– Vasculopathy – Double vision – Periodontal disease – Underdosage
– Dermatological conditions – Vision fluctuations – Oral Candida (thrush) – Overdosage
– Musculoskeletal problems – Cataracts – Adverse drug reactions
– Macular edema – Drug interactions
– Ocular nerve palsy – Undertreatment
Comprehensive Foot 






Strategies for Managing 
Drug Therapy:
– Loss of protective sensation – Visual acuity – Teeth – Use of medications
– Skin and nail condition – Visual fields – Gums – Monitoring treatment
– Absent pedal pulses – Pupillary reaction – Periodontal probing –  Self treatment and OTC 
medications
– Foot deformity – Intraocular pressure –  Intraoral lesions, 
infections, or masses
–  Selecting and using a 
blood glucose meter
– History of foot ulcers – Cranial nerves – Adequate saliva flow – Cost control
– Prior amputation – Slit-lamp exam
– Dilated retinal exam Coordination of Care
Table 5. Summary—What to Discuss with Patients with Diabetes
Foot Health and Diabetes
Section 5
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Foot Health and Diabetes
Prevalence of Foot Symptoms and Complications
Early manifestations of diabetes may present initially in the foot. Foot 
symptoms increase the risk for co-morbid complications, of which non-
traumatic lower-extremity amputations (LEAs) are the greatest concern. 
According to 1997 hospital discharge data, diabetes accounted for 
approximately 87,720 LEAs in the United States, fully 67% of all LEAs (31). 
Between 1980 and 2001, the number of diabetes-related hospital discharges 
with LEA increased from an average of 33,000 to 82,000 per year (32). 
LEA rates were highest among men, non-Hispanics/Latinos, African Americans, 
and the elderly. In 2003, there were about 75,000 diabetes-related hospital 
discharges with LEA. The LEA rate per 1,000 persons with diabetes that year 
was 3.9 among persons aged less than 65 years, 6.6 among persons aged 
65–74 years, and 7.9 among persons aged 75 years or older.
One study found that 80% of non-traumatic LEAs are preceded by a foot 
ulceration, which provides a portal for infection (33). According to Behavioral 
Risk Factor Surveillance Study (BRFSS) data, approximately 12% of U.S. adults 
with diabetes had a history of foot ulcer, a risk factor for LEA (34). Another 
report identified minor trauma, ulceration, and faulty wound healing as 
precursors to 73% of LEAs, often in combination with gangrene and infection 
(37). Other risk factors include the presence of sensory peripheral neuropathy, 
altered biomechanics, elevated pressure on the sole of the foot, and limited 
joint mobility (35).
The Charcot Foot
Patients with neuropathy are at risk for painless degenerative 
arthropathy that typically affects the tarsometatarsal and 
metatarsophalangeal joints, resulting in a red, swollen, and possibly 
deformed foot that can be mistaken for cellulitis. Radiographs 
may show collapse of joint structure, and can be misinterpreted as 
osteomyelitis. Treatment for Charcot arthropathy, however, is not 
antibiotics but a non-weight-bearing cast (once any acute edema has 
resolved) and special shoes to correct altered biomechanics. Without 
proper treatment, the Charcot foot can progress to further deformity, 
ulceration and lead ultimately to amputation.
Consider it a “red flag” when a patient complains that his shoes 
no longer fit, or is wearing slippers or shoes with sections cut out 
to accommodate changes in foot shape, or walks with a new limp. 
A Charcot foot usually causes little to no pain and may be slowly 
progressive over weeks to months before coming to a foot care 
provider’s attention. All health care providers can contribute to 
amputation prevention by referring patients with these signs and 
symptoms to a foot care specialist.
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People with diabetes who have neuropathy are 1.7 times more likely to 
develop foot ulceration; in persons with both neuropathy and foot deformity, 
the risk is 12 times greater; and in those who also have a history of pathology 
(prior amputation or ulceration), the risk is 36 times greater (36, 37). 
Factors that increase risk for lower-extremity ulceration and amputation are 
male sex, the existence of diabetes for more than 10 years, tobacco use, a 
history of poor glycemic control, or the presence of cardiac, retinal, or renal 
complications (38–40).
Foot Evaluation in People with Diabetes
Podiatrists use the following considerations to assess the risk for complications 
when evaluating the feet of people with diabetes.
 •  Neuropathy. The presence of subjective tingling, burning, numbness, or 
the sensation of bugs crawling on the skin may indicate peripheral sensory 
neuropathy. On clinical examination, this condition can be detected with an 
instrument known as a Semmes-Weinstein 5.07 (10 gram) monofilament. 
A description of how to use this monofilament to perform a comprehensive 
foot exam can be found in the free NDEP health care provider kit, Feet Can 
Last A Lifetime, http://www.ndep.nih.gov/diabetes/pubs/Feet_Kit_Eng.pdf.
 •  Vasculopathy. Cramping of calf muscles when walking (“charley horse”) 
that requires frequent rest periods suggests intermittent claudication. This 
condition, often caused by insufficient blood supply to the region beneath 
the knee, indicates the presence of early or moderate occlusion of the 
arteries that is common to the lower extremities of people with diabetes. 
Intense cramping and aching in the toes only at night, called “rest pain,” is 
usually relieved by hanging the feet over the side of the bed and by walking. 
This symptom signifies the end-stage blood vessel disorder and tissue 
ischemia that precedes diabetic gangrene. Although most clinical research 
Foot Complication Prevention
–  Up to 20% of people with diabetes who present for routine care will 
have a treatable foot care problem. Have the patient remove socks 
and shoes and inspect both feet for acute problems at each visit.
–  The lifetime incidence of foot ulcers among patients with diabetes is 
15%. Most of these are preventable though interventions available 
in most primary care settings.
–  Patients with diabetes on dialysis are at extreme risk for foot 
complications. Foot care programs that provide outreach to this 
group are associated with improved foot outcomes.
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continues to list the loss of sensation/neuropathy as the leading factor in 
ulceration and associated complications, poor blood supply can contribute 
to poor ulceration healing and is a significant risk factor for amputation. 
Both factors need to be addressed in comprehensive diabetes foot care 
with diagnostic testing for treatable vascular lesions and intervention as 
warranted.
 •  Dermatological conditions. Corns and calluses (hyperkeratotic 
lesions) of the feet result from elevated mechanical pressure and shearing 
of the skin. They often precede breakdown of skin and lead to blisters 
or ulceration. Superficial lacerations and heel fissures, or maceration 
(softening caused by wetness) between the toes, can all serve as portals for 
infection. Corns, calluses, toenail deformity, and bleeding beneath the nail 
may signify the presence of sensory neuropathy. Fungus infections of skin or 
nails can lead to secondary bacterial infections and should be treated.
 
 •  Musculoskeletal symptoms. Structural changes in the diabetic foot 
may develop in combination with muscle-tendon imbalances as a result of 
motor neuropathy. These deformities include the presence of hammertoes, 
bunions, high-arched foot, or flatfoot—all of which increase the potential 
for focal irritation of the foot in the shoe.
 •  Lifestyle and family history. People with diabetes who smoke are four 
times more likely than non-diabetic smokers to develop lower-extremity 
vascular disease. Unhealthy food choices and low physical activity levels 
contribute to poor long-term control of blood glucose and increase the 
risk that peripheral nervous system and/or blood vessel disorders will 
progress. A family history of cerebrovascular accidents and coronary artery 
disease may indicate a further increased risk of developing lower-extremity 
arterial complications. Inherited foot types (e.g., shapes) may predispose to 
biomechanical deformities that lead to problems with skin breakdown.
Comprehensive Foot Examination
A comprehensive foot examination for abnormalities, including evaluation of 
pulses, sensation, foot biomechanics (general foot structure and function), 
and nails helps determine the person’s category of risk for developing foot 
complications. Persons with diabetes who are at high risk have one or more of 
the following characteristics: (1) loss of protective sensation, (2) absent pedal 
pulses, (3) foot deformity, (4) history of foot ulcers, or (5) prior amputation. 
Low-risk individuals have none of these characteristics (41). Assessment of risk 
status identifies people who need more intensive care and evaluation. Further 
patient education, early intervention, and special footwear if indicated can 
prevent ulcers and ultimately LEAs.
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Patient Education
The goal for low-risk patients is to keep them at low risk through control of the 
ABCs and tobacco cessation in those who use tobacco. In high-risk patients, 
the goal is to prevent ulcers though self-management education, podiatry 
care, and proper use of appropriate footwear. Minor trauma, such as stubbing 
a toe or stepping on a sharp object, is the most frequent precipitating event 
leading to ulcer. Emphasize to patients and their families the need to be 
diligent in clearing the walking spaces, especially around the bed and the path 
to the bathroom, and to use night-lights. High-risk patients also need to know 
when and whom to call with specific foot problems. Patients with a puncture 
wound, ulcer, redness, or new-onset foot pain should call and see their 
primary care provider or podiatrist that day. Patients with callus and/or thick or 
ingrown nails should call a podiatrist and be seen within a few days.
Foot care educational materials for patients are available from NDEP in 
English and in Spanish at http://www.ndep.nih.gov/diabetes/pubs/Feet_
broch_Eng.pdf (42).
To obtain free print copies of these patient education materials, the Feet 
Can Last a Lifetime health care provider kit, and other materials on diabetes 
prevention and control visit http://www.ndep.nih.gov or call 1-800-438-5383.
Foot Risk Status
The American Diabetes Association and American Podiatric 
Medical Association consider two categories of risk for developing 
foot complications.
High Risk (one or more of the following):
(1) Loss of protective sensation.
(2) Absent pedal pulses.
(3) Foot deformity.
(4) History of foot ulcers.
(5) Prior amputation.
Low Risk: None of these characteristics.
See text for interventions for patients with high- and low-risk feet.
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High and Low-Risk Foot Patient Education
 The goal for low-risk patients is to keep them low risk:
 • Control the ABCs.
 • Tobacco cessation.
 The goal for high-risk patients is to prevent foot ulcers:
 • Self-management education:
 • Stress the role of minor trauma.
 • Clear walking spaces of potential hazards.
 • Prompt (same day) care for injuries.
 • Regular podiatry care.
 • Use appropriate footwear.
Eye Health and Diabetes
Section 6
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Eye Health and Diabetes
Diabetes is the leading cause of new cases of blindness among adults aged 
20 to 74 years. Diabetic retinopathy causes 12,000 to 24,000 new cases of 
blindness each year (43). People with diabetes can maintain optimal vision 
and healthy eyes by having an annual comprehensive vision examination, 
including a dilated eye examination, with early intervention if retinopathy is 
found.
Diabetes-related Eye Conditions
People with diabetes are at 25 times greater risk for blindness (44). People 
with diabetes who smoke, have poor nutrition, and do not control their 
diabetes have an even greater risk of developing eye complications. Because 
many people with diabetes have slower healing time, eye injuries—even minor 
corneal scratches—should not be taken lightly.
Retinopathy
Diabetic retinopathy (DR) is a common complication of diabetes. Elevated 
blood sugar damages the retinal blood vessels, causing them to break down, 
leak, or become blocked. Over time, this causes retinal hemorrhage and 
impaired oxygen delivery to the retina that can lead to the growth of abnormal 
vessels. These new vessels are fragile and can break easily, causing permanent 
vision loss. One in 12 people with diabetes aged 40 years and older has 
vision-threatening diabetic retinopathy (45). Studies have shown that aspirin 
use (e.g., for CVD prophylaxis) is safe in persons with retinopathy and has no 
adverse effect on the development or progression of diabetic retinopathy (46, 47).
Poor glycemic control and longer duration of diabetes lead to increased rates 
of retinopathy in people with type 1 and type 2 diabetes. Diabetic retinopathy, 
however, is treatable, and one of the most preventable causes of vision loss 
and blindness. The risks of DR are reduced through disease management of 
blood sugar, blood pressure, and lipid control. Early diagnosis and proper 
treatment reduce the risk of vision loss; however, as many as 50% of patients 
are not getting their eyes examined or are diagnosed too late for treatment 
to be effective. Individuals with diabetes are also at an increased risk for 
glaucoma and cataracts.
Early detection and treatment can prevent or delay blindness due to diabetic 
retinopathy in 90% of people with diabetes. Good glycemic control has been 
shown to reduce or delay by 76% the development of retinopathy in people 
with diabetes (47). Intensive therapy reduces the first appearance of any 
retinopathy by 27%. Retinal laser photocoagulation surgery can reduce the risk 
of severe vision loss from the worst form of the disease, proliferative diabetic 
retinopathy (PDR), to 4% percent or less (48).
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Optometrists and ophthalmologists can provide low-vision aids—from simple 
hand magnifiers to innovative optical devices—to help those who have 
experienced uncorrectable vision loss due to diabetic retinopathy. These eye 
care professionals can additionally provide or assure the provision of a full 
spectrum of care and services that may allow people with vision impairment 
and diabetes to maintain their independence and quality of life and help 
control their diabetes (e.g., to read instructions, take medication, continue with 
household tasks).
Other Common Eye Complications in Diabetes
Cataracts are a clouding of the eye lens most often caused by aging. The 
lens is responsible for focusing the images onto the retina, and thus a clouding 
of the lens can result in diminished vision and increased sensitivity to glare. 
Over half of all Americans aged 65 years and older have cataracts (3).
Glaucoma is a progressive disease that damages the optic nerve. It is this 
nerve that carries the retinal image to the brain, so disruption of this 
transmission can cause irreversible blind spots or field loss, which over time 
can lead to total blindness. A view of the optic nerve during a dilated eye exam, 
combined with visual field testing, intraocular pressure testing (IOP), and other 
tests can often reveal damage at an early stage, thus providing opportunity 
for treatment. It is important to note that IOP should never be used as a sole 
diagnostic indicator. Among Americans aged 40 years or older, 2.2 million 
have glaucoma and another 1.1 million are unaware of having the disease 
(46). For this reason, glaucoma often is referred to as the “silent thief of sight.” 
Glaucoma is twice as common among older black adults as among whites.
Double vision. People with diabetes may complain about sudden onset 
of double images. Because this can be due to damage to the nerves from 
the brain to the eye, it is important to see an optometrist or ophthalmologist 
immediately. This symptom can be misinterpreted by the patient or by a non-
eye care provider unfamiliar with this ocular complication as a sign of a stroke 
or other neurological problem, prompting unnecessary diagnostic procedures 
such as radiological exams. Double vision (or diplopia) may instead be due 
to mononeuropathy—damage to a single nerve—usually cranial nerves III, 
IV, or VI. The sixth and third nerves are most frequently affected. Third-nerve 
palsies occur with pupillary sparing in 80% of cases. Most diabetic third-nerve 
palsies usually resolve spontaneously within 2 to 3 months and the symptom of 
double vision can often be controlled with the use of special lenses.
Vision fluctuation. Poor control of blood glucose levels can lead to a 
fluctuation in vision. These temporary visual fluctuations occur because of 
fluid imbalance in the crystalline lens. When the glucose level is elevated, the 
lens thickens, causing vision changes that may increase nearsightedness or 
farsightedness. When the glucose level returns to normal, the lens can shrink 
back to its normal state. For those who need glasses, if the glucose level is 
poorly controlled, the constant state of flux can make it difficult to determine 
the best lenses.
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Comprehensive Dilated Eye Exam— 
How Often and by Whom?
 •  Most people with diabetes should have a dilated eye examination 
by an optometrist or an ophthalmologist annually.
 •  If a person with diabetes has had a normal result for their eye 
exam, an eye care provider may suggest less frequent exams 
(every 2–3 years (30).
 •  Examinations will be needed more frequently if retinopathy 
exists or is progressing.
People with diabetes should have an exam by an eye specialist. 
A primary care medical professional (physician, nurse practitioner, 
or physician assistant) does not have the training, or often the 
equipment, to do a comprehensive diabetes eye exam.
Oral Health and Diabetes
Section 7
34
Oral Health and Diabetes
Changes in the Oral Cavity
Diabetes can lead to changes in the oral cavity. Of particular concern 
to dentists and dental hygienists are the effects of diabetes on the health 
of the gingiva (gums) and periodontal tissues (49). Poor glycemic control 
is associated with gingivitis and more severe periodontal diseases (50–52). 
Oral signs and symptoms of diabetes can also include a neurosensory 
disorder known as burning mouth syndrome, taste disorders, abnormal wound 
healing, and fungal infections (candidiasis). Individuals with diabetes may 
notice a fruity (acetone) breath, frequent xerostomia (dry mouth), or a change 
in saliva thickness. Dry mouth can also lead to a marked increase in dental 
decay. Oral findings in people with diabetes are associated with other systemic 
findings such as excessive loss of fluids through frequent urination, altered 
response to infection, altered connective tissue metabolism, neurosensory 
dysfunction, microvascular changes, medications causing dry mouth, and 
possible increased glucose concentration in saliva (53). Smoking often makes 
these problems worse. Unfortunately, caring for the mouth is often overlooked 
when trying to control other problems associated with diabetes. Good oral 
hygiene combined with good glycemic control can prevent many of these 
problems.
Periodontal Disease
People with diabetes are two to three times more likely than persons without 
diabetes to have destructive periodontal disease, such as periodontitis (54). 
Periodontal disease is a bacterially induced, chronic inflammatory disease that 
destroys the connective tissue and bone supporting the teeth and can lead 
to tooth loss. Periodontal disease is more prevalent, progresses more rapidly, 
and is often more severe in individuals with both type 1 and type 2 diabetes 
(55). Recent research suggests a two-way connection between diabetes and 
periodontal disease. Not only are people with diabetes more susceptible to 
periodontal disease, but the presence of periodontal disease may also make 
glycemic control more difficult (56-59). Proper care of the mouth that includes 
treatment of peridontal disease may help people with diabetes achieve better 
glycemic control.
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Some studies have suggested a relationship between insulin resistance and 
inflammatory mediators. The inflamed periodontal tissue, which can be 
equivalent to an area as large as an adult palm, is highly vascular and may 
become ulcerated. This infection may introduce inflammatory mediators, 
as well as bacterial lipopolysaccharides and other toxins, into the systemic 
circulation. Some of the inflammatory mediators produced in periodontitis 
also stimulate the liver to produce acute-phase proteins, such as C-reactive 
protein (CRP), serum amyloid A, and fibrinogen. These proteins can be 
elevated in the peripheral blood of patients with periodontitis (60) and are 
associated with harmful effects on organs. Thus, periodontal inflammation 
potentially contributes to a systemic, chronic inflammatory state that also 
is a component of other inflammation-related diseases, including diabetes 
mellitus, cardiovascular diseases, and others. Treatment of periodontal disease 
decreases periodontal inflammation, and evidence is accumulating to support 
periodontal treatment contributing to improvement of glycemic control (61).
Figure 6. U.S. Adults, Ages 45+, with Severe, “Active” 





















Source:  NHANES III *1+sites: LPA 6+mm and gingival bleeding
36
Signs and symptoms of severe periodontal disease can include 
red, swollen, tender and bleeding gums; gums that have pulled away from 
the teeth; pus between the gums when they are compressed; persistent bad 
breath or bad taste in the mouth; permanent teeth that are loose or moving 
apart; any change in the way the teeth fit together when the patient bites; and 
any change in the fit of removable partial dentures. Most people with diabetes 
do not experience pain with periodontal disease, and many have periodontal 
disease and be asymptomatic. This highlights the importance of regular 
professional check-ups and care. Periodontal probing performed by a dentist 
or dental hygienist is a primary diagnostic assessment tool and can be used to 
measure response to treatment.
Recognize Oral Signs that may 
be Symptomatic for Diabetes:
 • Xerostomia
 - Dry mouth may also cause an increase in dental decay
 • Periodontal (gum) disease
 - Red, swollen or bleeding gums
 - Gums pulling away from teeth
 - Abscesses (pus) between gums
 - Loose teeth or change in bite or tooth position
 • Candidal infection (thrush)
 • Persistent bad breath or bad taste, or fruity, acetone odor




Drug Therapy Management and Diabetes
Drug therapy management has traditionally been concerned with ensuring 
correct dosage, avoiding drug interactions, and educating patients about 
possible side effects. People identified as being at high risk for medication-
related problems include those with chronic and multiple diseases, those who 
take multiple (five or more) medications, and those who see multiple health 
care providers. Because people with diabetes often fall into these categories, 
drug therapy management is especially important. It includes comprehensive 
reviews of medication and medical records, education of patients to improve 
compliance with medication regimens, and an assessment of individual 
response to therapy to ensure timely interventions and coordination and 
continuity of care.
Drug-related Problems
Today’s pharmaceuticals and advanced medical technologies provide 
many therapeutic options for treating diabetes and its comorbidities. If 
used inappropriately, however, they can cause serious illness, long-term 
disability, or even death. A study released in February 2001 shows that 
misuse of prescription drugs in the United States costs $177 billion annually 
in additional treatments, hospital care, and doctor visits, up from $76.5 
billion in 1995. More important than the costs, however, the study estimates 
that 218,000 prescription drug-related deaths annually are due to misused 
prescription medications (62). The study identifies several categories of drug-
related problems, including improper drug choice, underdosage, overdosage, 
adverse drug reactions, drug interactions, and undertreatment. Additional 
identified factors include untreated medical conditions and medication use 
with no indication (63, 64). More than 50% of those with chronic disorders 
do not take their medication properly. Over 60% of persons with diabetes do 
not adequately control their blood glucose. Of persons treated for high blood 
pressure and high cholesterol, 65% and 49%, respectively, are unable to reach 
target blood pressure and total cholesterol levels (65). To improve compliance 
and minimize these health care adversities, medication therapy regimens must 
be consistently and carefully monitored. Correct use of medication improves 
health and saves money for the health care system (66–68).
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Strategies for Managing Drug Therapy
People with diabetes should establish a relationship with a pharmacist who 
can help monitor drug regimens, advise how to take medications properly, 
and provide other information to help them control their diabetes. Strategies 
include the following:
 •  Use of medications. Individualize drug regimens to determine the 
best time to take medications to reduce side effects and drug interactions. 
Offer behavior strategies, compliance aids, appropriate dosage forms, 
and a drug delivery system.
 •  Self-treatment and over-the-counter medications. Ask patients 
with diabetes if they are using nonprescription medications; vitamin, herbal, 
or nutritional supplements; or topical and skin-care products. Assess the 
severity and urgency of the person’s complaint, the appropriateness for self-
treatment, and any precautions and contraindications. Recommend self-
treatment, follow-up, and/or referral to another health care professional, 
as appropriate.
One study reported that over 57% of people with diabetes use complemetary 
and alternative therapies (69).
 •  Selecting and using a blood glucose meter. Help the patient 
choose an appropriate blood glucose meter and provide training on how 
to use it. Educate the person about the results, actions to take, and when 
to seek help. Self-monitoring blood glucose (SMBG) is an important way to 
assess the effectiveness of therapy.
 •  Cost control. Advise on ways to decrease costs of medications and 
supplies by providing information on private insurance plans, prescription 
drug programs, Medicare and Medicaid, the role of generic medications, 






Coordination of care presents many challenges when delivered by multiple 
providers in a variety of settings. Changes in drug therapy may occur when 
patients see specialty providers or during acute illness or hospitalization. When 
a case includes multiple disease states and multiple drugs, along with OTC 
drugs, herbal products, and other supplements, diligent case management is 
required to ensure continuity of care that is well coordinated (69).
As an extension of the dispensing role of pharmacists, central medication 
review and drug therapy management (including nonprescription products) 
can ensure that a current drug therapy plan is appropriately implemented. 
In one study, collaborative drug therapy management (CDTM), provided by 
pharmacists in collaboration with other health care providers, resulted in 
identification of problems in 65% of patients’ drug regimens (70). In other 
studies, CDTM resulted in decreased morbidity and mortality, as well as 
decreased costs attributable to fewer unscheduled physician visits, urgent care 
visits, emergency room visits, and hospital days (71–73).
With coordinated care, all members of the health care team, including the 
patient, benefit from having a primary resource to deliver intended drug 
therapy, information, and monitoring for effectiveness and adverse effects. 
This coordination will help ensure adherence to the intended treatment plan 
and identify drug and disease management problems in a timely manner.
Coordination of Care:
 •  Engage clinic leadership in establishing diabetes quality care in the 
strategic plan.
 • Support a designated diabetes coordinator and diabetes team.
 •  Provide self-management education services according to the 
NDEP and ADA standards.
 • System redesign:
 -Use registries and tracking systems for appointments.
 -Prescreen charts to prepare for the office visit.
 -Case management through a care coordinator.
 •  Decision support such as flow sheets and electronic health record 
automated prompts.
 • Establish links to community resources.




Pre-diabetes and Primary Prevention
An estimated 54 million Americans aged 40 to 74 years (40.1% of the U.S. 
population in this age group) have pre-diabetes, a condition that puts them 
at high risk for developing type 2 diabetes. Without intervention, people with 
pre-diabetes will progress to type 2 diabetes at a rate of 10% per year. Pre-
diabetes also increases the risk of heart disease and stroke (3).
Pre-diabetes is a condition in which blood glucose levels are higher than 
normal but not in the diabetes range. Pre-diabetes is defined as impaired 
fasting glucose (IFG) of 100 to 125 mg/dl or impaired glucose tolerance 
(IGT) diagnosed by a post 75-gram glucose challenge (oral glucose tolerance 
test or OGTT) of >140 to <200 mg/dl or both IFG and IGT. (See appendix 
B for more information on blood glucose testing.) The Am I at Risk for Type 
2 Diabetes? brochure, produced by the National Institute of Diabetes and 
Digestive and Kidney Diseases (NIDDK), can help patients and providers 
assess individual risk for Pre-diabetes.
Primary Prevention
Primary prevention refers to preventing diabetes from occurring. Secondary 
prevention refers to preventing complications in those who already have 
diabetes (e.g., prevention of neuropathy) and tertiary prevention refers to 
prevention of worsening complications (e.g., amputation resulting from injury 
to a neuropathic foot) or death.
The burden of diabetes is high. On average, more than 4,100 people are 
diagnosed with diabetes every day. On average, 55 go blind, 120 experience 
kidney failure, and 230 have a limb amputated every day. The rate of 
prevalence increase is high. In the past 25 years, the number of Americans 
with diabetes has more than tripled (from 5.8 million to 20.8 million), and 
future projections are high.
Trend is not Destiny
Type 2 diabetes can be prevented or delayed. A major clinical trial—the 
Diabetes Prevention Program (DPP) study—provided scientific evidence that the 
onset of diabetes could be prevented or delayed in people at high risk. In the 
DPP, adults with Pre-diabetes reduced their risk of developing diabetes during 
the course of the study by 58% through such lifestyle changes as:
 • Reduced fat and calorie intake.
 •  Increased physical activity of at least 150 minutes/week (e.g., brisk walking 
30 minutes a day, 5 days/week).
 • Loss of more than 5% to 7% of body weight.
It is estimated that of persons born in America in 2002, 1 in 3 will 
develop diabetes in his or her lifetime. For Hispanic/Latino women, 
the statistic is 1 in 2…unless something changes.
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These lifestyle changes were effective in preventing or delaying diabetes in 
all ages and all ethnic groups in the DPP. Among people aged 60 years and 
older, progression to type 2 diabetes was reduced by 71%. The DPP showed 
that moderate changes resulting in modest weight loss can make a difference (9).
DPP participants have been enrolled in a continuation study and follow-up 
data will be forthcoming. Further information on pre-diabetes, testing 
recommendations, and information on the NDEP’s Small Steps. Big Rewards. 
Prevent Type 2 Diabetes. campaign and tools can be found on the NDEP Web 
site at http://ndep.nih.gov/campaigns/SmallSteps/SmallSteps_index.htm.
The Role of PPOD Providers in Primary Prevention
All health care providers can play a role in diabetes primary prevention and 
diabetes control. As a pharmacist, podiatrist, optometrist, dentist, or dental 
hygienist, you can make a difference in primary prevention:
 • You know your patients.
 • Your patients trust you.
 • A few words from you can go a long way.
 •  You can determine with just a few questions who is at high risk for diabetes 
(see risk factor list below).
Do Your Patients Have any of the Following Risk 
Factors?
 • Family history of type 2 diabetes.
 • Overweight or obesity.
 • High blood pressure or cholesterol.
 •  African American, American Indian/Alaska Native, Asian American, 
Hispanic/Latino, Native Hawaiian/Pacific Islander ethnicity.
 • Pre-diabetes.
 • Age of more than 45 years.
 • History of gestational diabetes (GDM).
Gestational Diabetes Mellitus (GDM)
It is estimated that women who have had GDM have a 20% to 50% likelihood 
of developing type 2 diabetes in the 5 to 10 years following pregnancy. 
Without intervention, progression from Pre-diabetes to type 2 diabetes occurs 
at a rate of approximately 10% per year. With NDEP resources and self-
management support for behavior change, diabetes can be prevented 
or delayed.
Test Value Diagnosis
FPG* 100–125 mg/dL IFG (pre-diabetes)
FPG >125 mg/dL Diabetes
OGTT** 2-hour value 140–199 mg/dL IGT (pre-diabetes)
OGTT 2-hour value >200mg/dL Diabetes
*FPG = fasting plasma glucose




A Few Words Can Go a Long Way
You don’t need to do it all—resources are available to help. Your patients will 
appreciate that you care about their overall health
Ask: “Has anyone ever told you that you are at risk for diabetes?”
Advise: “You can take action to prevent or delay type 2 diabetes.”
Assist: Give your patients resources to help them make healthy changes:
 • Refer to a primary care provider.
 • Use the free primary prevention materials available from the National 
Diabetes Education Program (NDEP)—call 1-800-438-5383, visit 
www.ndep.nih.gov or use the order form in the Appendix.
Primary Prevention Hypothetical Cases
 •  A 30-year-old woman at a routine dental hygienist appointment shares 
that fact that she recently delivered a nine-pound baby after a pregnancy 
complicated by GDM. She exclaims “Thank goodness that’s all over!” 
The dental hygienist tells her of the high lifelong risk of developing type 2 
diabetes in women who have had GDM. The patient learns about the free 
NDEP materials available to help her lose weight and prevent or delay the 
onset of type 2 diabetes.
 •  A 45-year-old African American woman brings her mother in for her annual 
comprehensive diabetes eye exam. The eye care provider asks if she ever 
considered that she, too, might be at risk for developing diabetes. The 
woman is surprised. “Me? I just never thought much about it. I’ve always 
been focused on Mama.” The eye care provider gives the woman the Am I 
At Risk? brochure, NDEP’s toll-free number and Web site URL, and suggests 
she make a follow-up appointment with her own primary care provider.
 •  A 50-year-old man accompanied by his overweight teenage son asks the 
pharmacist about weight loss pills. The pharmacist asks to talk to both 
father and son together. The teen seems embarrassed and unconvinced. 
He says “What am I supposed to eat when the guys are all eating 
cheeseburgers and fries after school?!” The pharmacist agrees that 
changing eating habits is hard, but not impossible. Smaller portions, or 
choosing a plain hamburger instead of the oversized one with cheese, can 
make a difference. He suggests the family take a look at NDEP’s Web site 
for tip sheets on healthy eating and physical activity, and that they talk to 
a dietitian. Dad agrees to play basketball with his son a couple of nights a 
week—good exercise for both of them.
 •  A 70-year-old man consults a podiatrist because of painful corns on his 
feet. He says “I don’t walk anymore because of these corns, but I guess 
that doesn’t matter—I’m too old to be walking much now.” The podiatrist 
emphasizes the many benefits of regular physical activity such as walking, 
including diabetes prevention. He explains that 1 in 5 people over age 60 
have diabetes, but that the disease can be prevented or delayed. He shares 
the NDEP “It’s Not Too Late to Prevent Diabetes” tip sheet with the man and 
points out NDEP’s toll-free number and URL. He says, “After we get these 
corns fixed up, I want to see you out there walking!”
Always advise 
patients to check 
with their primary 
care provider 
before beginning an 





Set Up a Referral System
Integrated, multidisciplinary team care is key to successful diabetes 
management, and coordination of care can be facilitated by setting up a 
system of referrals for routine preventive care as well as for urgent needs.
Create a mechanism for preventive care and urgent referrals; don’t just tell 
the person with a potentially serious problem to consult a health specialist 
right away. Contact primary care and specialty providers to discuss with them 
criteria and ensure that procedures are in place for seeing a person who 
is referred for preventive care or an urgent basis.
Make a list of providers, case managers, phone numbers, and other contact 
information; keep it handy for quick reference. Consider giving individuals 
handouts with referral information, or calling clinics directly for urgent referrals.
Check the NDEP health care providers’ Web site, 





Diagnosis is based on plasma glucose levels obtained from a venous sample 
(74). Information on diagnostic criteria, relative merits of different screening 
tests, and an algorithm for evaluating people at risk can be found at 
http://ndep.nih.gov/ddi/#HC. Blood glucose testing can be performed 
using different methods for different purposes.
Screening refers to testing asymptomatic individuals at high risk for diabetes 
via venous sample (preferred) or a capillary sample to determine if follow-up 
diagnostic testing is indicated (75).
Blood glucose testing to monitor glycemic status by patients and health care 
providers is considered a cornerstone of diabetes care. Results of monitoring 
are used to assess the efficacy of therapy and guide adjustments in medical 
nutrition therapy (MNT), exercise, and medications to achieve the best possible 
glucose control (76).
Blood glucose testing by people with diabetes—self-monitoring of blood 
glucose (SMBG)—is recommended for all people with type 1 diabetes. 
For most such patients, SMBG three or more times a day is recommended. 
For people with type 2 diabetes, the frequency of testing should be sufficient 
to facilitate reaching glucose goals. The frequency of testing should be 
increased with therapy modification (77).
Because the accuracy of SMBG depends on both the instrument and the user, 
the technique should be evaluated by a health care provider initially and then 
periodically (78).
Requirements for Laboratory Testing
All health care providers who perform finger sticks or other laboratory 
testing must be registered with the Centers for Medicare & Medicaid Services 
(CMS) under the Clinical Laboratory Improvement Amendment (CLIA), which 
established quality standards to ensure the accuracy, reliability, and timeliness 
of patient test results regardless of where the test is performed. Three 
categories of tests and certification have been established, depending 
on the complexity of the test method. CLIA has established compliance 
regulations for each level of testing that require quality control and 
documentation procedures (79).
Certain states have established additional requirements for various sites 
or health care providers. For specific additional requirements, health care 
providers should contact their state agency (see http://www.cms.hhs.gov/clia 
for contact information). Compliance with the Occupational Safety and Health 
Administration’s regulations for bloodborne pathogens must also 
be documented and maintained.
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Appendix C
Multidisciplinary Care in Action
People with diabetes may present with a complaint best treated with 
multidisciplinary care. Common symptoms or concerns and possible 
presentation and management scenarios are given below as examples.
Foot and Skin Care
 • Dry skin.
 • Wounds, fungal and bacterial infections, ulcers.
 • Pain, numbness, tingling of extremities.
 • Corns, calluses, bunions, ingrown toenails.
Example:
A person requests a foot soak from the pharmacist for an ingrown toenail. 
Assessment reveals that he or she has diabetes and for 3 weeks has had a 
severely inflamed ingrown toenail that has not responded to topical antibiotic 
ointment. The pharmacist discusses with the person the relationship between 
diabetes and its complications, as well as the need to seek immediate 
attention from a podiatrist or primary care physician. The pharmacist also 
emphasizes that people with diabetes should NOT soak their feet. Soaking 
dries the skin and can cause more skin and foot complications.
Eye Health
 • Dry itchy eyes.
 • Blurred vision, poor vision (seeking reading glasses).
 • Eye pain.
 • Conjunctivitis.
 •  Other eye problems such as partial vision, hemorrhages, floaters, “spots,” 
foreign objects, contact lens problems.
Example:
A 45-year-old woman tells her podiatrist that she can’t check her feet because 
she “just can’t see as well” as she used to. She was recently diagnosed with 
diabetes. She assumed that she needed reading glasses, but has not had an 
eye exam because she never had poor vision before. The podiatrist recognizes 
that the patient’s blurred vision could be a sign of poor glucose control or eye 
pathology, and explains to her the relationship between diabetes and vision 
problems, both transient and long term. The podiatrist then refers the patient 
to an optometrist or an ophthalmologist for a comprehensive eye examination, 
including pupil dilation, and to a primary care provider for follow-up.
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Oral Health
 • Sore, red, inflamed, bleeding gums.
 • Toothache, pain, infections.
 • Dry mouth.
 • Candida infections.
 • Denture pain.
 • Cold sores, canker sores.
Example:
A person with diabetes asks the pharmacist for a product to use as a mouth 
rinse for irritated gums. Assessment reveals that the person has poorly 
controlled diabetes and symptoms consistent with oral candida infection. 
The pharmacist briefly explains the relationship between diabetes and oral 
health, and refers the patient to a dentist for treatment. Follow-up care for 
diabetes with a primary care provider is also arranged.
Medication Management
 • Multiple medications.
 • Varying instructions on how to take medications.
 • Drug-drug interactions.
 • Over-the-counter treatments, herbals, home remedies.
 • Symptoms attributed to medication side effects.
Example:
A dental hygienist asks if a patient’s medications have changed since the 
last visit and discovers the patient is confused about how to take a newly 
prescribed medicine. The patient asks if “twice a day” means with breakfast 
and dinner, morning and bedtime, or at precise times such as 8 a.m. and 
8 p.m. He further asks if the medication may be taken at the same time as 
other medications, because he takes several other medications for blood 
pressure and cholesterol as well as glucose control. He states: “It’s hard 
to find time to take all these medicines in one day!” The dental hygienist 
reinforces the importance of taking the medicine as directed, and suggests 
consulting with the provider who prescribed the medicines and with the 
pharmacist to ask these questions. The pharmacist may be more immediately 
accessible, can provide counseling on potential drug interactions, and can 




Medication Supplement and Patient Education Poster
Working Together to Manage Diabetes has two companion pieces: a Working 
Together Medications Supplement and patient education poster (available 
in English and Spanish).
The Working Together Medications Supplement is a quick reference guide 
to medications commonly used by people who have diabetes, and is intended 
to help providers understand these medications. For complete prescribing 
information, please consult the package inserts or the Physicians’ Desk 
Reference.
PPOD providers and others not only can use the Working Together 
Medications Supplement to reinforce patient education messages about 
medication use, but also to coordinate team care. For example:
 •  Types of insulin and timing of their administration may help the PPOD 
provider schedule a procedure at an appropriate time.
 •  Awareness of common medication-related symptoms can help a non-
primary care provider recognize a potential problem and make a referral.
 •  Adverse interaction of medications prescribed by multiple providers can 
be reduced.
 •  Inadvertent over and underdosing can be lessened if the entire health 
care team is aware of medication names (both generic and trade names), 
strengths, and dosing frequency.
 •  Every patient interaction is an opportunity to reinforce correct use of 
medication and to refer as needed to the primary care clinician and 
pharmacist for individualized drug therapy counseling.
The Working Together to Manage Diabetes patient education poster focuses 
on the steps a person with diabetes can take to team up with their PPOD 
providers for foot, eye, and oral health care and medication management. 
The poster emphasizes proactive “I will” statements and shows photos of 
PPOD providers interacting with patients. The poster can be hung in a waiting 
room, the public area of a pharmacy or community hall, or used as a prompt 
on key messages in one-on-one patient counseling.
The Working Together Medications Supplement and patient education posters 
are available for downloading from www.ndep.nih.gov and are copyright-free. 
Single free hard copies can be ordered via the National Diabetes Education 
Program Web site or by calling 1-800-438-5383.
Additional Resources
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American Academy of Ophthalmology
http://www.aao.org/
The American Academy of Ophthalmology has more than 27,000 members 
worldwide. Academy members are doctors of medicine or osteopathy who 
specialize in the eyes and vision. The majority are practicing physicians 
who provide the full spectrum of eye care, from prescribing glasses and 
contact lenses, to the medical and surgical treatment of a wide variety of eye 
conditions. In addition, many are subspecialists with special training who focus 
their practices in specific areas of ophthalmology such as glaucoma, cataract, 
or pediatric ophthalmology.
American Academy of Optometry
http://www.aaopt.org
Founded in 1922, the goal of the American Academy of Optometry is to 
maintain and enhance excellence in optometric practice by fostering research 
and the dissemination of knowledge in both basic and applied vision science.
American Academy of Periodontology
http://www.perio.org
The mission of the American Academy of Periodontology is to advance the 
periodontal health of the public and to represent and serve the Academy’s 
members. It provides clinical and scientific publications as well as consumer 
information.
American Association of Clinical Endocrinologists
http://www.aace.com
The American Association of Clinical Endocrinologists is a professional 
medical organization devoted to the enhancement of the practice of clinical 
endocrinology. Its members are physicians with special education, training, 
and interest in the practice of clinical endocrinology.
American Association of Diabetes Educators
800-TEAM-UP4
http://www.aadenet.org
The American Association of Diabetes Educators is a multidisciplinary 
organization representing health care professionals who provide diabetes 
education and care. It provides continuing education and products for health 
care professionals in all settings.
American College of Clinical Pharmacy
http://www.accp.com
The American College of Clinical Pharmacy provides leadership, education, 
advocacy, and resources to enable clinical pharmacists to achieve excellence 
in practice and research. It provides research forums, continuing education, 




The American Dental Association is the professional association of dentists 
committed to the public’s oral health, as well as ethics, science, and 
professional advancement. It provides continuing education and a monthly 
journal for dentists, in addition to consumer education on oral health topics.
American Dental Hygienists Association
800-243-ADHA
http://www.adha.org/
The American Dental Hygienists Association is the largest professional 
organization representing the interests of dental hygienists. It provides 
continuing education through its Institute for Oral Health, as well as 





The American Diabetes Association funds research; publishes scientific 
findings; provides information and other services to people with diabetes, their 
families, health care professionals, and the public; and advocates for scientific 




The American Dietetic Association is the nation’s largest organization of food 
and nutrition professionals. Its mission is to promote optimal nutrition and 
well-being for all people by advocating for its members.
American Optometric Association
http://www.aoa.org
The mission of the American Optometric Association is to influence the future 
of eye care by ensuring the welfare of the public and promoting the profession 
of optometry. Its objectives are centered on improving the quality and 
availability of eye and vision care.
American Pharmacists Association
http://www.aphanet.org
The American Pharmacists Association is the largest national professional 
society of pharmacists. It is a leader in providing professional information and 
in advocating for the improved health of the American public through the 
provision of comprehensive pharmaceutical care.
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American Podiatric Medical Association
http://www.apma.org
The American Podiatric Medical Association represents approximately 80% of 
the nation’s podiatrists and has more than 20 affiliated and related societies. 
Its mission is to increase awareness among other health professionals and the 
public concerning the importance of foot health.
American Public Health Association
http://www.apha.org
The American Public Health Association is the oldest and largest organization 
of public health professionals in the world, representing more than 50,000 
members from over 50 occupations of public health. The Association brings 
together researchers, health service providers, administrators, teachers, and 
other health workers in a unique, multidisciplinary environment of professional 
exchange, study, and action.
American Society of Health-System Pharmacists
http://www.ashp.org
The American Society of Health-System Pharmacists represents pharmacists 
who practice in hospitals and other components of health care systems. 
It provides extensive publishing, education, and accreditation programs 
designed to help members improve their delivery of pharmaceutical care.
HRSA Health Disparities Collaboratives
http://www.healthdisparities.net
The Health Disparities Collaboratives is a program that includes the Bureau 
of Primary Health Care, Institute for Healthcare Improvement, National 
Association of Community Health Centers, Inc., and other strategic partners, 
to generate and document improved health outcomes for underserved 
populations; transform clinical practice through models of care, improvement, 
and learning; develop infrastructure, expertise, and multidisciplinary leadership 
to support and drive improved health status; and build strategic partnerships.




CDC’s Division of Diabetes Translation aims to reduce the nation’s burden 
of diabetes by strengthening public health surveillance systems, conducting 
applied transnational research, developing state-based diabetes control 
programs, implementing the National Diabetes Education Program (NDEP), 
and providing public information.
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Centers for Medicare & Medicaid Services
410-786-3000
http://www.cms.gov
The Centers for Medicare & Medicaid Services, formerly known as the 
Health Care Financing Administration, is the federal agency responsible for 
administering Medicare, Medicaid, the State Children’s Health Insurance 
Program, and several other health-related programs.
Indian Health Services Diabetes Program
http://www.ihs.gov/MedicalPrograms/Diabetes/index.asp
The Indian Health Service provides health care to 1.6 million Native 
Americans and Alaska Indians from more than 550 federally recognized 
tribes across the nation. Diabetes is a major concern among the treatment 
population and the Division of Diabetes Treatment and Prevention has made 
numerous tools and information available on their Web site to assist with this 
epidemic, including best practices for eye care, foot care, oral health, and 
pharmaceutical care.
National Association of Chain Drug Stores
http://www.nacds.org
The National Association of Chain Drug Stores provides a wide range of 
services to meet the needs of the chain drug industry, including publications 
for members and information for consumers.
National Community Pharmacists Association
http://www.ncpanet.org
The National Community Pharmacists Association represents the nation’s 
community pharmacists, including the owners of nearly 24,000 independent 
pharmacies that generate more than $67 billion in annual sales and dispense 
nearly half of all retail prescriptions. The Association is committed to high-
quality pharmacist care and to promoting the health and well being of the 
public.





The National Diabetes Education Program brings together public and private 
partners to improve treatment and outcomes for people with diabetes, 
promote early diagnosis, and prevent the onset of type 2 diabetes. It promotes 
awareness and education activities and quality care. The Web site provides 
tools for educating health care providers and patients.
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National Diabetes Information Clearinghouse
800-860-8747
http://diabetes.niddk.nih.gov
The NIDDK’s National Diabetes Information Clearinghouse is an information 
and referral service designed to increase knowledge about diabetes among 




The National Eye Institute conducts and supports research to help prevent and 
treat eye diseases and other disorders of vision, including diabetic retinopathy. 
It also develops public and professional education programs, including the 
National Eye Health Education Program, a partnership of more than 65 
organizations concerned with eye health.
National Heart, Lung, and Blood Institute
301-592-8573
http://www.nhlbi.nih.gov
The National Heart, Lung, and Blood Institute provides leadership for a 
national program in diseases of the heart, blood vessels, lungs, and blood; 
blood resources; and sleep disorders. It supports research, develops and 
evaluates interventions, and conducts educational activities with an emphasis 
on prevention.
National Institute of Dental and Craniofacial Research
http://www.nidcr.nih.gov
The National Institute of Dental and Craniofacial Research (NIDCR) conducts 
and supports research and the training of researchers to promote the oral, 
dental, and craniofacial health of the American people, prevent oral diseases 
and conditions, and develop new diagnostics and therapeutics. Two useful 
publications developed for consumers are Diabetes: Dental Tips and Prevent 
Diabetes Problems: Keep Your Teeth and Gums Healthy.
National Institute of Diabetes and Digestive and Kidney 
Diseases
http://www.niddk.nih.gov
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
conducts and supports basic and clinical research on the treatment and 
prevention of diabetes and other serious diseases affecting metabolism and 
the endocrine system, digestion and nutrition, the kidneys and urinary tract, 
and the blood and blood-forming organs.
National Optometric Association
http://www.natoptassoc.org
The National Optometric Association promotes the recruitment of minority 
students for schools and colleges of optometry and their placement into 
appropriate practice settings upon graduation. It also works to enhance the 
delivery of eye and vision care services in communities with little or no eye 
care presence.
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Selected Publications for Health Care Providers and Patients
(This list represents only a sample of materials available—please consult the 
Web sites indicated.)
Available from the Centers for Disease Control and Prevention (CDC)
http://www.cdc.gov/diabetes/pubs/tcyd/index.htm :
 • Take Charge of Your Diabetes
Available from the National Diabetes Education Program (NDEP)
(See order form at end of appendices.)
http://www.ndep.nih.gov :
 •  Your GAMEPLAN for Preventing Type 2 Diabetes: Health Care Providers’ 
Toolkit
 • Your GAMEPLAN for Preventing Type 2 Diabetes: Information for Patients
 • Team Care: Comprehensive Lifetime Management for Diabetes
 •  Feet Can Last a Lifetime: A Health Care Provider’s Guide to Preventing 
Diabetes Foot Problems
 • Diabetes Numbers At-a-Glance (card for health care providers)
 • Be Smart About Your Heart
 • 7 Principles for Controlling Your Diabetes
 • If You Have Diabetes, Know Your Blood Sugar Numbers
 • Control Your Diabetes. For Life. Tips for Feeling Better and Staying Healthy
 • Asian language patient materials
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